Advancing early gastric cancer detection

Abstract

Important factors in combating cancer are early detection and accurate assessment of the best course of treatment. In a study published in this issue, Wang et al. identify possible miRNA biomarkers for improved determination of gastric cancer stage and prognosis. In particular, they show increased miR‐194 levels are a predictor of more favourable gastric cancer prognosis, at least in part due to miR‐194 downregulating production of a key protein for cancer development: CCND1.

Keywords

• biomarker
• gastric cancer
• miRNA
• miR‐194
• prognosis
• the cancer genome atlas